OWLT
Owlet, Inc.
NYSE · Healthcare · Medical - Devices · US
$4.98
−0.99%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 114.9M | 105.7M | 78.1M | 54.0M | 69.2M |
| Cost of Revenue | 52.0M | 52.2M | 38.7M | 31.4M | 45.9M |
| Gross Profit | 62.9M | 53.5M | 39.3M | 22.6M | 23.3M |
| Operating Expenses | |||||
| R&D Expense | 16.0M | 14.1M | 9.8M | 10.3M | 27.9M |
| SG&A Expense | 54.5M | 47.7M | 49.7M | 40.9M | 80.0M |
| General & Admin Expense | 33.8M | 29.2M | 34.0M | 27.3M | 41.5M |
| Selling & Marketing Expense | 20.6M | 18.5M | 15.8M | 13.5M | 38.5M |
| Other Expenses | (100.0K) | — | — | — | — |
| Total Operating Expenses | 70.3M | 61.8M | 59.5M | 51.2M | 107.9M |
| Cost and Expenses | 122.3M | 114.0M | 98.3M | 82.6M | 153.8M |
| Operating Income (EBIT) | (7.4M) | (8.3M) | (20.2M) | (28.6M) | (84.6M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 2.8M | 3.4M | 1.6M | 3.2M | 1.1M |
| Net Interest Income | (2.8M) | (3.4M) | (1.6M) | (3.2M) | (1.1M) |
| Other Non-Op Income/Expense | (1.6M) | (31.4M) | 7.7M | (4.3M) | 5.3M |
| Non-Operating Income (excl Interest) | (1.2M) | 28.0M | (9.4M) | 1.1M | (6.4M) |
| EBT (Pre-Tax Income) | (9.0M) | (39.6M) | (12.5M) | (32.9M) | (79.3M) |
| Income Tax Expense | (10.0K) | 28.0K | 54.0K | 10.0K | 29.0K |
| Bottom Line | |||||
| Net Income | (9.0M) | (39.7M) | (12.5M) | (32.9M) | (79.3M) |
| Earnings from Cont. Ops | (9.0M) | (39.7M) | (12.5M) | (32.9M) | (79.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (12.9M) | (41.9M) | (12.5M) | (37.5M) | (79.3M) |
| Per Share | |||||
| Basic EPS | ($0.43) | ($2.24) | ($1.55) | ($4.53) | ($9.98) |
| Diluted EPS | ($0.46) | ($2.24) | ($1.55) | ($4.53) | ($9.98) |
| Revenue Per Share | $4.03 | $5.67 | $7.02 | $6.53 | $8.70 |
| Shares | |||||
| Basic Shares Outstanding | 28.5M | 18.7M | 11.1M | 8.3M | 8.0M |
| Diluted Shares Outstanding | 28.5M | 18.7M | 11.1M | 8.3M | 8.0M |
| Profitability Metrics | |||||
| EBITDA | (5.7M) | (35.6M) | (9.5M) | (27.5M) | (75.5M) |
| D&A | 505.0K | 590.0K | 1.4M | 2.2M | 2.7M |
| EBIT | (6.2M) | (36.2M) | (10.9M) | (29.7M) | (78.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026